Know Cancer

or
forgot password

EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy


N/A
18 Years
90 Years
Open (Enrolling)
Both
Mediastinal Lymphadenopathy, Lung Cancer

Thank you

Trial Information

EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy


A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung
cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness
is far less. This study primarily focusing on merged approach of cytology, histopathology
and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.


Inclusion Criteria:



- Age > 18 years old

- mediastinal lymphadenopathy on Chest CT scan

- with a short-axis > 10mm

Exclusion Criteria:

- patients intolerant to bronchoscopy exam

- unstable vital sign (Blood pressure, heart rate, breath rate)

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Diagnostic rate

Outcome Time Frame:

Participant will be followed within an average of three months

Safety Issue:

Yes

Principal Investigator

Chih-Hso Kuo, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Chang Gung Memorial Hospital

Authority:

Taiwan: Department of Health

Study ID:

EBUSTBNA_01

NCT ID:

NCT01493739

Start Date:

January 2009

Completion Date:

January 2012

Related Keywords:

  • Mediastinal Lymphadenopathy
  • Lung Cancer
  • Lung Neoplasms
  • Lymphatic Diseases

Name

Location